Karolis Urbonas

Mr. Karolis Urbonas


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
NSNadezda Scupakova
Nadezda Scupakova
KUKarolis Urbonas
Karolis Urbonas
AJAgne Jankuviene
Agne Jankuviene
LPLina Puodziukaite
Lina Puodziukaite
PAPovilas Andrijauskas
Povilas Andrijauskas
Robertas Stasys SamalavičiusRobertas Stasys Samalavičius
Robertas Stasys Samalavičius
Background: The age limit for the use of extracorporeal membrane oxygenation (ECMO) support for post-cardiotomy cardiac failure is not defined. The aim of the study was to evaluate the outcomes of octogenarians supported with ECMO due to cardiogenic shock. Methods: A retrospective review of consecutive elderly patients supported with ECMO during a 13-year period in a tertiary care center. Patient’s demographic variables, comorbidities, perioperative data and outcomes were collected from patient medical records. Data of octogenarian patients were compared with the septuagenarian group. The main outcomes of the study was in hospital mortality, 6-month survival and 1-year survival after hospital discharge and discharge options. Multivariate logistic regression analysis was performed to identify the factors associated with hospital survival. Results: Eleven patients (18.3%) in the elderly group were octogenarians (aged 80 years or above), and forty-nine (81.7%) were septuagenarians (aged 70–79 years). There were no differences except age in demographic and preoperative variables between groups. Pre ECMO SAVE, SOFA, SAPS—II and inotropic scores were significantly higher in septuagenarians than octogenarians. There was no statistically significant difference in hospital mortality, 6-month survival, 1 year survival or discharge options between groups. Conclusions: ECMO could be successfully used in selected octogenarian patients undergoing cardiac surgery to support a failing heart. An early decision to initiate ECMO therapy in elderly post-cardiotomy shock patients is associated with favorable outcomes.

25 August 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
AZAleksejus Zorinas
Aleksejus Zorinas
VJVilius Janušauskas
Vilius Janušauskas
Donatas AustysDonatas Austys
Donatas Austys
GDGiedrius Davidavičius
Giedrius Davidavičius
LPLina Puodziukaite
Lina Puodziukaite
KRKęstutis Ručinskas
Kęstutis Ručinskas
Background: There is a lack of studies where the outcomes of mitral paravalvular leak treatment were compared between surgery and catheter-based closure. The aim of this study was to compare the outcomes of re-do surgery with transapical catheter-based paravalvular leak closure. Methods: This is a retrospective observational study at a single institution; 76 patients were included. According to the treatment, two groups were formed: the “Surgical” group (49 patients after re-do surgery) and the “Catheter” group (27 patients after transapical catheter–based treatment). Results: In-hospital myocardial infarction occurred in 9 (18%) cases in the “Surgical” group and none in the “Catheter” group, p = 0.018. Procedure-related life-threatening bleeding occurred in 9 (18%) patients in the “Surgical” group and none in the “Catheter” group, p = 0.018. Nine (18%) patients died in 30 days in the “Surgical” group, and none died in the “Catheter” group, p = 0.039. A mean follow-up was 3.3 years. No difference was found between the groups by the degree of residual paravalvular regurgitation either at discharge or at follow-up. During the follow-up, 19 (39%) patients died in the “Surgical” group and 2 (7%) among the “Catheter” patients. Conclusions: Transapical catheter-based closure of mitral paravalvular leak seems to be a safer treatment procedure than conventional re-do surgery, and the effectiveness of these procedures does not differ.

1 January 2025 in Computational and Structural Biotechnology Journal
Verified
Journal Article
Open access
AAAudrius Andrijauskas
Audrius Andrijauskas
PAPovilas Andrijauskas
Povilas Andrijauskas
DDDarius Dilijonas
Darius Dilijonas
IJIeva Jovaisiene
Ieva Jovaisiene
AVArūnas Valaika
Arūnas Valaika
TJTomas Jovaisa
Tomas Jovaisa
Summary: Purpose: This prospective observational clinical study investigated discrepancy between noninvasive continuous haemoglobin (SpHb, Masimo Corp., Irvine, CA) measurements with sensors placed on three fingertips during elective cardiac surgery. Materials and methods: The study included 12 adult patients who underwent elective coronary artery bypass grafting (CABG) under cardiopulmonary bypass (CPB). Three identical versions of SpHb sensors were placed on the fingers of the same hand and connected to dedicated Masimo Radical-7 monitors. Data were continuously recorded throughout the surgery. Multiple group comparison tests—Kruskal Wallis and Alexander Govern tests—were used to compare three sets of SpHb data (trends). Bland Altman and Giavarina plots were used to compare the SpHb data with invasive arterial haemoglobin (Lab-Hb) data obtained at clinically relevant time points chosen at the discretion of the cardiac anaesthesiologist, who was blinded to the study protocol. Results: There was a good correlation between the time-matched SpHb data from the three sensors at 253 time points (r = 0.86–0.95), but there was a significant difference between the SpHb values obtained from each sensor and the average SpHb value of all 3 sensors (p < 0.05) at each time point. The absolute difference between the SpHb value obtained from each sensor and the average SpHb value was 0.69 g/dl g/dl (SD 1.49 g/dl). The accuracy and precision of the average SpHb for estimating Lab-Hb was higher compared to the SpHb values obtained from two out of three individual sensors (sn1 and sn3) and very similar compared to values obtained from sensor sn2. Conclusion: The sensor placement site can impact the SpHb measurement causing discrepancy between SpHb measured in different fingers. The average SpHb from three fingertips appears to be more accurate and precise in estimating Lab-Hb. However, more advanced sensors are needed.

20 February 2025 in Medicina
Verified
Journal Article
Open access
PDF file
AAAudrius Andrijauskas
Audrius Andrijauskas
PAPovilas Andrijauskas
Povilas Andrijauskas
IJIeva Jovaišienė
Ieva Jovaišienė
AVArūnas Valaika
Arūnas Valaika
TJTomas Jovaisa
Tomas Jovaisa
Edgaras StankeviciusEdgaras Stankevicius
Edgaras Stankevicius
The medical industry is an integral part of the delivery of healthcare. Collaboration between academic institutions, healthcare providers, and the industry are necessary but not devoid of flaws. This expert opinion article calls for closer attention to be paid by the medical industry to “what a frontline clinician needs” rather than relying solely on experts’ opinions and stake holders’ requests in planning future products and features. The need for the monitoring of tissue fluid accumulation is discussed from the point of view of practicing anaesthesiology and intensive care specialists in the context of the potential missed opportunity to have it be already available.